Redoblado, Merlinda .

HRN: 19-71-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/09/2024
11/15/2024
IVT
2.25g
Q8
Chronic Otitis Media
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: